Role of Neutral Sphingomyelinase-2 in aging

中性鞘磷脂酶 2 在衰老中的作用

• 批准号: 7213668
• 负责人: Mariana N Nikolova-Karakashian
• 金额: $ 28.66万
• 依托单位: UNIVERSITY OF KENTUCKY
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-02-15 至 2012-01-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7213668
• 关键词: Acute-Phase Proteins; Acute-Phase Reaction; Adenoviruses; Affect; Age; Age of Onset; Aging; Aging-Related Process; Animal Model; Animals; Anti-Inflammatory Agents; Anti-inflammatory; Attenuated; Bypass; CCAAT-Enhancer-Binding Proteins; Caloric Restriction; Cell Aging; Cell Line; Cells; Cellular Stress Response; Ceramides; Characteristics; Cytokine Signaling; Defect; Development; Doctor of Philosophy; Dose; Elderly; End Point; Endocrine; Exhibits; Figs - dietary; GW 4869; Gene Silencing; Genes; Glutathione; Glutathione Disulfide; Goals; Hepatocyte; IRAK1 gene; Immune system; In Vitro; Incidence; Inflammation; Inflammatory; Injection of therapeutic agent; Interleukin-10; Interleukins; Link; Liver; Longevity; MAPK8 gene; Measures; Mediating; Mediator of activation protein; Molecular; Neuroglia; Oligonucleotides; Organism; Oxidative Stress; Pattern; Peritoneal Macrophages; Pharmaceutical Preparations; Phenotype; Play; Process; Protein Overexpression; Protein Phosphatase 2A Regulatory Subunit PR53; Rate; Rattus; Research Personnel; Role; Signal Pathway; Sphingomyelinase; Stream; Stress; Testing; Transcriptional Activation; Ubiquitination; Up-Regulation; adenoviral-mediated; aged; biological adaptation to stress; feeding; functional decline; human IRAK1 protein; immune function; in vivo; inhibitor/antagonist; juvenile animal; mortality; novel; practical application; prevent; programs; receptor; research study; response; scyphostatin

DESCRIPTION (provided by applicant): Aging is characterized by an altered immune function and stress response. It becomes increasingly clear that, at least in part, this is due to alterations in ability of the cells to respond to different stress inducers. The hypothesis to be tested in this proposal is that aging-induced up-regulation of neutral sphingomyelianse-2 (NSMase-2) activity underlies the exaggerated response of hepatocytes IL-1beta during aging. We further hypothesized that aging-associated increases in NSMase-2 activity are consequence of the decreases in the cellular glutathione level. Therefore, the long-term objective of our study is to understand the relation between aging, the altered cellular response to inflammation, and the state of oxidative stress. The following specific aims are proposed: Specific aim 1. To test the role of NSMase-2 as a mediator of aging-induced hyperresponsiveness to IL-1b. Studies in this specific aim will decipher the contribution of NSMase-2 to the IL-1b hyperresponsiveness of aged animals. Gene silencing approach will be used in vitro, in hepatocytes isolated from old rats, and in vivo, in aged animals. Specific aim 2. To study the IL-1b hyperresponsiveness in calorie-restricted aged rats. Calorie-restriction (CR) is known to increase the life span of experimental animals and to attenuate the onset of oxidative stress, including preventing aging-induced GSH/GSSH decline. Thus we hypothesized that CR attenuates IL-1B hyperresponsiveness of liver. This will be tested in vivo and in vitro. If NSMase-2 mediates IL-1b hyperresponsiveness by acting down-stream of GSH/GSSH changes, then NSMase-2 overexpression in aged CR should restore the aging-associated IL-1b hyperresponsiveness. This will be tested by adenoviral-mediated expression of NSMase-2 in isolated hepatocytes and intact liver from aged CR rats. Specific aim 3: To study the role of GSH in aging-associated NSMase-2 activation and IL-1b hyperresponsiveness. These studies will ask whether GSH depletion in aging and NSMase-2 activation are causatively linked and will establish a link between the onset of oxidative stress and the IL-1b hyperesponsivness in aged animals. The proposed studies will provide novel understanding on the cellular mechanisms involved in the onset of aging and may have practical application in the development of new anti-inflammatory drugs for the elderly.

描述（由申请人提供）：衰老的特征是免疫功能和应激反应的改变。越来越清楚的是，至少在一定程度上，这是由于细胞对不同应激诱导剂的反应能力发生了变化。本研究要验证的假设是，衰老诱导的中性鞘磷脂-2 （NSMase-2）活性上调是衰老过程中肝细胞il -1 β反应过度的基础。我们进一步假设，衰老相关的NSMase-2活性增加是细胞谷胱甘肽水平下降的结果。因此，我们研究的长期目标是了解衰老、细胞对炎症反应的改变和氧化应激状态之间的关系。提出以下具体目标：测试NSMase-2在衰老诱导的对IL-1b高反应性中的作用。这一特定目的的研究将破译NSMase-2对老年动物IL-1b高反应性的贡献。基因沉默方法将在体外用于从老年大鼠分离的肝细胞，在体内用于老年动物。具体目标2。研究限热老龄大鼠IL-1b高反应性。已知热量限制（CR）可以延长实验动物的寿命，减轻氧化应激的发生，包括防止衰老引起的GSH/GSSH下降。因此，我们假设CR降低了肝脏IL-1B的高反应性。这将在体内和体外进行测试。如果NSMase-2通过作用GSH/GSSH变化的下游介导IL-1b高反应性，那么NSMase-2在老年CR中的过表达应该可以恢复衰老相关的IL-1b高反应性。这将通过腺病毒介导的NSMase-2在老年CR大鼠分离肝细胞和完整肝脏中的表达来验证。特异性目的3：研究谷胱甘肽在衰老相关NSMase-2激活和IL-1b高反应性中的作用。这些研究将探讨衰老过程中GSH的消耗和NSMase-2的激活是否存在因果关系，并将在衰老动物的氧化应激发作和IL-1b高反应性之间建立联系。本研究将对衰老发生的细胞机制提供新的认识，并可能在开发新的抗衰老药物方面具有实际应用价值。